Literature DB >> 21289255

Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study.

Chevon M Rariy1, Sarah J Ratcliffe, Rachel Weinstein, Shalender Bhasin, Marc R Blackman, Jane A Cauley, John Robbins, Joseph M Zmuda, Tamara B Harris, Anne R Cappola.   

Abstract

CONTEXT: The physiological importance of endogenous testosterone (T) in older women is poorly understood.
OBJECTIVE: The aim of the study was to determine the association of higher total and free T levels with bone mineral density (BMD), lean body mass, and fat mass in elderly women.
DESIGN: Total and free T were measured using sensitive assays in 232 community-dwelling women aged 67-94 yr who were enrolled in the Cardiovascular Health Study and had dual-energy x-ray absorptiometry scans. Cross-sectional analyses were performed to examine associations between total and free T and BMD and body composition.
RESULTS: In adjusted models, total T was directly associated with BMD at the lumbar spine (P = 0.04) and hip (P = 0.001), but not body composition outcomes, in all women, and after excluding estrogen users and adjusting for estradiol (P = 0.04 and 0.01, respectively). Free T was positively related to hip BMD, lean body mass, and body fat (all P < 0.05), with more than 10% differences in each outcome between women at the highest and lowest ends of the free T range, with attenuation after excluding estrogen users and adjusting for estradiol.
CONCLUSIONS: In the setting of the low estradiol levels found in older women, circulating T levels were associated with bone density. Women with higher free T levels had greater lean body mass, consistent with the anabolic effect of T, and, in contrast to men, greater fat mass. Mechanistic studies are required to determine whether a causal relationship exists between T, bone, and body composition in this population and the degree to which any T effects are estrogen-independent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289255      PMCID: PMC3070250          DOI: 10.1210/jc.2010-0926

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

2.  Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W S Browner; J A Cauley; H K Genant; S R Mascioli; J C Scott; D G Seeley; P Steiger
Journal:  JAMA       Date:  1990-02-02       Impact factor: 56.272

3.  Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; W S Browner; D Bauer; K Stone; K Ensrud; S Jamal; B Ettinger
Journal:  N Engl J Med       Date:  1998-09-10       Impact factor: 91.245

4.  Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study.

Authors:  G A Greendale; S Edelstein; E Barrett-Connor
Journal:  J Bone Miner Res       Date:  1997-11       Impact factor: 6.741

5.  The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women.

Authors:  I Sinha-Hikim; S Arver; G Beall; R Shen; M Guerrero; F Sattler; C Shikuma; J C Nelson; B M Landgren; N A Mazer; S Bhasin
Journal:  J Clin Endocrinol Metab       Date:  1998-04       Impact factor: 5.958

6.  Design of the Fracture Intervention Trial.

Authors:  D M Black; T F Reiss; M C Nevitt; J Cauley; D Karpf; S R Cummings
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

7.  Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study.

Authors:  Hermien W Goderie-Plomp; Marjolein van der Klift; Willem de Ronde; Albert Hofman; Frank H de Jong; Huibert A P Pols
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

8.  Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment.

Authors:  Indrani Sinha-Hikim; Wayne E Taylor; Nestor F Gonzalez-Cadavid; Wei Zheng; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

9.  Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

Authors:  S R Davis; P McCloud; B J Strauss; H Burger
Journal:  Maturitas       Date:  1995-04       Impact factor: 4.342

10.  Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon; G G Klee; B L Riggs
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

View more
  18 in total

1.  Longitudinal changes over three years in sex steroid hormone levels in women aged 70 years and over.

Authors:  Rakibul M Islam; Robin J Bell; David J Handelsman; Penelope J Robinson; Rory Wolfe; Susan R Davis
Journal:  Clin Endocrinol (Oxf)       Date:  2021-01-02       Impact factor: 3.478

2.  Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.

Authors:  Sean M Hartig; Bin He; Justin Y Newberg; Scott A Ochsner; David S Loose; Rainer B Lanz; Neil J McKenna; Benjamin M Buehrer; Sean E McGuire; Marco Marcelli; Michael A Mancini
Journal:  Chem Biol       Date:  2012-09-21

3.  Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.

Authors:  Grace Huang; Elizabeth Tang; Adam Aakil; Stephan Anderson; Hernan Jara; Maithili Davda; Helene Stroh; Thomas G Travison; Shalender Bhasin; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2014-04-08       Impact factor: 5.958

4.  The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.

Authors:  Serra Ucer; Srividhya Iyer; Shoshana M Bartell; Marta Martin-Millan; Li Han; Ha-Neui Kim; Robert S Weinstein; Robert L Jilka; Charles A O'Brien; Maria Almeida; Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2015-07       Impact factor: 6.741

Review 5.  Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

Authors:  Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

6.  Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Ricardo Azziz
Journal:  Hum Reprod       Date:  2014-05-09       Impact factor: 6.918

7.  Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period.

Authors:  Carolyn J Crandall; Chi-Hong Tseng; Arun S Karlamangla; Joel S Finkelstein; John F Randolph; Rebecca C Thurston; Mei-Hua Huang; Huiyong Zheng; Gail A Greendale
Journal:  J Clin Endocrinol Metab       Date:  2013-02-26       Impact factor: 5.958

8.  Inactivation of the androgen receptor in bone-forming cells leads to trabecular bone loss in adult female mice.

Authors:  Jorma A Määttä; Kalman G Büki; Kaisa K Ivaska; Vappu Nieminen-Pihala; Teresa D Elo; Tiina Kähkönen; Matti Poutanen; Pirkko Härkönen; Kalervo Väänänen
Journal:  Bonekey Rep       Date:  2013-11-06

Review 9.  Benefits and Consequences of Testosterone Replacement Therapy: A Review.

Authors:  Polackwich As; Tadros Nn; Ostrowski Ka; Hedges Jc
Journal:  Eur Endocrinol       Date:  2013-03-15

10.  Comment on: Wehr et al. Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women. Diabetes Care 2011;34:1771-1777.

Authors:  Nitesh D Kuhadiya; Sandeep Dhindsa; Paresh Dandona
Journal:  Diabetes Care       Date:  2012-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.